M2
← Portfolio

Equity Research · Current Holding

Tesla

TSLA · NASDAQ · Electric Vehicles · Autonomy

Rating

Underweight · Short

Cover Target

$300

Quan Pham, Senior Analyst · M’Squared Capital Research · As of Q2 2026

Priced as an AI and robotics company while the core auto business decelerates into intensifying competition.

Summary

Tesla's valuation capitalizes Full Self-Driving, robotaxi, and Optimus optionality while the auto business faces margin compression, softening volume, and Chinese competition. We are short the gap between narrative and near-term numbers, with a target of $300.

Business Overview

Tesla sells electric vehicles and energy-storage systems and is investing in autonomy (FSD and robotaxi) and humanoid robotics (Optimus). Autos remain the vast majority of revenue and cash flow today.

Short Thesis

  1. 01

    Auto deceleration

    Volume growth has stalled and price cuts compressed automotive gross margin. A growth-stock premium is hard to defend on a core business that is no longer growing.

  2. 02

    Optionality is carrying the cap

    Robotaxi and Optimus carry most of the market capitalization yet remain unproven on timeline, regulation, and unit economics.

  3. 03

    Competition and demand

    BYD and legacy OEMs are eroding share and pricing globally, and demand elasticity is worse than the bulls assume once incentives are stripped out.

Valuation & Downside

Our $300 target reflects a re-rating toward auto-plus-energy fundamentals while still crediting a generous option value for autonomy — below current levels that embed near-certain robotaxi success.

Catalysts

  • Delivery and margin misses
  • Robotaxi timeline slippage or safety incidents
  • Further price-cut cycles
  • Key-person and governance headlines

Key Risks

  • An FSD or robotaxi breakthrough re-rating the stock
  • Energy-storage growth surprising to the upside
  • Retail and momentum-driven short squeezes
  • Narrative catalysts from a promotional management

Bottom Line

Short the narrative-to-numbers gap. Underweight / short, target $300.

This note is the opinion of M’Squared Capital and is provided for informational purposes only. It is not investment advice, nor an offer or solicitation to buy or sell any security. Price targets and entry and exit levels reflect the firm’s proprietary views and realized transactions; they are not forecasts of future results. The firm may hold, add to, reduce, or close any position at any time without notice. Past performance is not indicative of future results.